Top of this page
Skip navigation, go straight to the content

Research & Development

UCB's goal is to command a leading position in discovering and developing new therapies to treat patients suffering from severe diseases. With a strong pipeline, our focus is on central nervous system (CNS) disorders and immunology diseases to provide new treatments for specialists and their patients.

Our key features

  • Patients are at the heart of all we do, driving our commitment to the treatment of severe diseases
  • A focus on these therapeutic areas: central nervous system (CNS) and immunology
  • An international R&D organization comprised of UCB New MedicinesTM and UCB Global Projects and Development
  • A track record of successful partnerships with both academia and leading drug discovery organizations. Partnership is part of our philosophy

One UCB approach

Our philosophy is to have a "one team" approach to drug discovery and development with seamless integration of research, development and commercial colleagues, in a process of continual learning and confirming as we examine our data and capitalize on our knowledge.

More information on UCB global research and development on the
UCB Corporate Web site.